Frequency and determinants of pregnancy-induced child-specific sensitization

American Journal of Transplantation

Volumn 13, Issue 3, 2013, Pages 746-753

  Honger G ^a   Fornaro, I ^a   Granado, C ^a   Tiercy, J M ^b   Hosli I ^a   Schaub, S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Allo sensitization; HLA antibodies; pregnancy; risk assessment; transplantation

Indexed keywords

HLA A ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA B49 ANTIGEN; HLA B51 ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FLUORESCENCE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; LIVE BIRTH; MAJOR CLINICAL STUDY; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; SENSITIZATION; SPONTANEOUS ABORTION;

ADULT; ALLELES; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HLA ANTIGENS; HUMANS; HYPERSENSITIVITY; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS;

EID: 84874433843     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12048     Document Type: Article

References (18)

1. Gebel HM, Bray RA, Nickerson P,. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk. Am J Transplant 2003; 3: 1488-1500.
2. Dunn TB, Noreen H, Gillingham K, et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 2011; 11: 2132-2143.
3. Scornik JC, Meier-Kriesche HU,. Blood transfusions in organ transplant patients: Mechanisms of sensitization and implications for prevention. Am J Transplant 2011; 11: 1785-1791.
4. van Kampen CA, Versteeg-vd Voort Maarschalk MF, Langerak-Langerak J, Roelen DL, Claas FH,. Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum Immunol 2002; 63: 452-458.
5. Rebibou JM, Chabod J, Alcalay D, et al. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 2002; 74: 537-540.
6. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H,. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999; 39: 103-106.
7. Regan L, Braude PR, Hill DP,. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6: 294-298.
8. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-1835.
9. Middelburg RA, Porcelijn L, Lardy N, Briet E, Vrielink H,. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011; 100: 327-335.
10. Endres RO, Kleinman SH, Carrick DM, et al. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion 2010; 50: 1749-1760.
11. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J,. " Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111-1115.
12. Scornik JC, Ireland JE, Salomon DR, Howard RJ, Fennell RS, III, Pfaff WW,. Pretransplant blood transfusions in patients with previous pregnancies. Transplantation 1987; 43: 449-450.
13. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P,. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 1995; 181: 2085-2095.
14. Dankers MK, Roelen DL, Korfage N, et al. Differential immunogenicity of paternal HLA Class I antigens in pregnant women. Hum Immunol 2003; 64: 600-606.
15. Dankers MK, Roelen DL, Van Der Meer-Prins EM, et al. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28. Transplantation 2003; 75: 418-420.
16. Doxiadis II, Smits JM, Schreuder GM, et al. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet 1996; 348: 850-853.
17. Duquesnoy RJ,. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847-862.
18. Dankers MK, Witvliet MD, Roelen DL, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004; 77: 1236-1239.